Earnings release
Page 1
SABIC EARNINGS RELEASE THIRD QUARTER 2026 October 25th, 2026
Page 2
SABIC Earnings Release 2 The Saudi Basic Industries Corporation (“SABIC”) (2010-SA) today announced its financial results for the third quarter of 2026, reporting a 14% increase in revenue, and a 40% increase in Adjusted EBITDA Q-o-Q. Third quarter 2026 highlights: • Revenue of SAR 28.17 billion [US$ 7.51 billion], an increase of 14% Q-o-Q. • Adjusted2 EBITDA1 of SAR 4.75 billion [US$ 1.27 billion], an increase of 40% Q-o-Q. • Adjusted2 EBIT3 of SAR 2.17 billion [US$ 0.58 billion], an increase of 434% Q-o-Q. • Adjusted2 Net (Loss) Income4 of SAR 0.84 billion [US$ 0.22 billion] compared to an adjusted Net (loss) of SAR (0.38) billion [US$ (0.1) billion] in Q2. • Adjusted2 Earnings Per Share4 of SAR 0.28 [US$ 0.07] Compared to an adjusted Earnings Per Share of SAR (0.13) [US$ (0.03)]. • Net debt position of SAR 3.03 billion [US$ 0.81 billion] as of September 30, 2026, compared to a net debt position of SAR 2.73 billion [US$ 0.73 billion] as of June 30, 2026.
Page 3
SABIC Earnings Release 3 Dr. Faisal ALFAQEER, CEO and Executive Board Member: “In 3Q2026, SABIC demonstrated exceptional resilience, despite geopolitical developments and market headwinds, coupled with a clear and robust forward-looking vision and continued focus on strategic objectives, namely portfolio optimization, transformation and selective growth, in efforts to support the company’s long-term profitability and value creation for shareholders, building on its historic journey of more than five decades. Quarterly key highlights included achieving an exceptional Total Recordable Incident Rate of 0.06, demonstrating our prioritization of safety and security; SABIC Agri -Nutrients’ Final Investment Decision to build a new industrial complex for ammonia and urea production in the Kingdom, with total annual production capacity of 1.2 million metric tons for ammonia and 2.6 million metric tons per annum for urea, increasing the company’s urea’s production capacity by 54% compared to current levels; the allocation of necessary feedstock by the Ministry of Energy for a new methanol production plant in Jubail, Kingdom of Saudi Arabia with a production capacity of 1.8 million tons per year, propelling our growth plans in strategic profitable markets; the completion of the divestment of the Engineering Thermoplastics business in the Americas and Europe for an enterprise value of $450 million, as part of our Portfolio Optimization Program; taking further steps in our transformation journey, whereby $0.95 billion (SAR 3.56 billion) was so far achieved of the 2030 target of $3 billion (SAR 11.25 billion) as a positive recurring impact on the EBITDA level; and receiving a Local Content Certificate for 2025 from the Local Content and Government Procurement Authority, as SABIC achieved over 61% as Local Content Score in 2025, an increase of more than 9% compared to 2024, an accomplishment that was further supported by concluding several agreements focused on local industries’ enablement, such as the recently signed MoU with Leno vo.”
Page 4
SABIC Earnings Release 4 Summary Financial Results: Item Three Months Ended Nine Months Ended Sep 30, 2026 June 30, 2026 Sep 30, 2025 Sep 30, 2026 Sep 30, 2025 Revenue 28.17 24.81 29.08 79.13 88.57 EBITDA1 4.74 3.79 5.04 12.67 13.38 Adjusted2 EBITDA1 4.75 3.38 5.09 12.28 14.57 Income from operations (EBIT3) 2.06 0.71 2.28 4.22 5.25 Adjusted2 EBIT3 2.17 0.41 2.34 4.02 6.47 Net (loss) income4 0.5 (0.83) 0.44 (0.32) (4.84) Adjusted2 net (loss) income4 0.84 (0.38) 1.37 1.28 3.47 Net income (loss) from continuing operations4 2.53 (0.08) 1.48 3.27 1.83 Earnings per share4 (SAR) 0.17 (0.28) 0.14 (0.11) (1.61) Adjusted2 earnings per share4 (SAR) 0.28 (0.13) 0.46 0.43 1.16 Earnings per share from continuing operations4 0.84 (0.03) 0.49 1.09 0.61 Free cash flow5 5.61 (1.40) 4.34 3.94 3.86 1Income from operations (EBIT) plus depreciation, amortization, and impairment 2Reflects SABIC's underlying operational performance based on normal course of business by eliminating the effects of non-operational anomalies and one- offs. 3Earnings before interest and tax 4Attributable to equity holders of the parent 5Net cash from operating activities minus capital expenditure All amounts in SAR billion unless otherwise stated, USD/SAR conversion used is 3.75. Absolute figures and percentages include d in this document have been subject to rounding adjustments. Certain prior quarter and prior year figures have been subject to rec lassifications. Please refer to the third quarter 2026 Financial Statements. SABIC reported revenue of SAR 28.17 billion [US$ 7.51 billion] in Q3 2026, reflecting a 14% increase compared to Q2 2026. This increase was primarily driven by 30% higher sales volume Q-o-Q as seen in a 24% increase in Chemicals sales, 23% increase in Polymers, and an increase in Agri Nutrients sales by 68%. Sales volume increases across the board were the results of SABIC’s effort to navigate logistical challenges through successful shipments via Strait of Hormuz and west ports utilization. The sales volume increase was partially offset by lower average selling prices across some key products as shown in the segments part. Despite the increase in the logistical cost, EBITDA was SAR 4.74 billion [US$ 1.26 billion], an increase of 25% compared to Q2 2026. On an adjusted basis, EBITDA increased by 40% Q-o-Q, mainly due to higher sales volume and improved margins as a result of lower liquid feedstock costs. The EBITDA margin was 16.81%, while the adjusted EBITDA margin reached 16.87%, up from 13.64% in Q2 2026. The increase in adjusted EBITDA margin reflects the higher sales and improved margins which were mainly due to reduction in liquid feedstock costs. Net Income from Continuing Operations was SAR 2.53 billion [US$ 676 million], on an adjusted basis however, the net income was SAR 843.76 million [US$ 225 million]. The difference is mainly attributed to reversal of impairment in Clariant as a result of its share price appreciation. Free cash flow of SAR 5.61 billion [US$ 1.5 billion] YTD 2026. An increase of 2% compared with same period last year due to optimized CAPEX spending as part of SABIC’s broader transformation efforts.
Page 5
SABIC Earnings Release 5 Business Results by reporting segment: 1. Petrochemicals: Petrochemicals Financial Overview: Item Three Months Ended Nine Months Ended Sep 30, 2026 Jun 30, 2026 Sep 30, 2025 Sep 30, 2026 Sep 30, 2025 Gross Revenue 22.95 20.47 23.89 65.18 73.78 EBITDA3 4.01 2.77 3.50 9.14 9.34 Adjusted2 EBITDA3 3.90 2.37 3.55 8.63 10.35 Income from operations (EBIT1) 1.70 0.08 1.14 1.87 2.39 Adjusted2 EBIT1 1.69 (0.19) 1.19 1.60 3.40 All amounts are in SAR billion unless otherwise stated. The USD/SAR conversion rate used is 3.75. Absolute amounts and percentages shown in this document have been subject to rounding adjustments. Please refer to the third quarter of 2026 Financial Statements. 1Earnings before interest and tax 2Reflects SABIC's underlying operational performance based on normal course of business by eliminating the effects of non-operational anomalies and one-offs. 3Income from operations (EBIT) plus depreciation, amortization, and impairment The Petrochemicals segment covers two SABIC businesses: Chemicals, and Polymers. o Total Petrochemicals sales volume of 6.71 MMT during Q3 2026 an increase of 24% compared to last quarter. Chemicals sales volume was 3.67 MMT higher by 24%, and Polymers sales volume was 2.95 MMT which was 23% higher Q-o-Q. Chemicals: • In Q3 2026, monoethylene glycol prices increased supported by historically low inventories in Asia caused by continued shipping disruptions from the Middle East. Demand was on the lower side, with low polyester Operating Rates in Asia, decrease of North America demand after world cup, and Europe remained weak with ample PET import. • Methanol (MEOH) prices lowered from high Q2 on lower upstream and weaker Asian demand. US and Europe followed lower Asian trend. Lower Asian demand on poor methanol-to-olefin margins and weak formaldehyde production was offset by better demand in West on higher AA and MTBE production in US and fuel related demand in Europe. • Methyl tert-butyl ether (MTBE) prices strengthened on higher gasoline values from better demand in both Asia and Europe due to summer driving season and favorable blending economics. Polymers: • In Q3 2026, polyethylene prices lowered across regions from high Q2 with anticipated easing of SoH early in the quarter. Supply up globally helped by export from US and improved local production is Asia. Demand was up in Asia up on lower prices. • Polypropylene prices lower across regions from high Q2 due to lower upstream costs. Stable to lower demand in key regions and buying sentiment remains cautious. • Polycarbonate prices saw mixed trends; Asian prices lowered on weaker upstream and supply increase. US prices stable, and Europe prices pressured on additional imports. Demand remained generally weak and buyers stayed cautious amid macro and geopolitical uncertainty.
Page 6
SABIC Earnings Release 6 2. Agri-Nutrients: Agri-Nutrients Financial Overview: Item Three Months Ended Nine Months Ended Sep 30, 2026 Jun 30,2026 Sep 30, 2025 Sep 30, 2026 Sep 30, 2025 Gross Revenue 3.22 2.40 3.40 8.33 9.64 EBITDA3 0.65 0.68 1.42 2.70 3.74 Adjusted2 EBITDA3 0.60 0.68 1.42 2.65 3.82 Income from operations (EBIT1) 0.45 0.49 1.22 2.12 3.10 Adjusted2 EBIT1 0.40 0.49 1.22 2.07 3.18 All amounts in SAR billion unless otherwise stated. The USD/SAR conversion rate used is 3.75. Absolute amounts and percentages shown in this document have been subject to rounding adjustments. Please refer to the third quarter of 2026 Financial Statements. 1Earnings before interest and tax 2Reflects SABIC's underlying operational performance based on normal course of business by eliminating the effects of non-operational anomalies and one-offs. 3Income from operations (EBIT) plus depreciation, amortization, and impairment o Total Agri-Nutrients sales volume of 1.62 MMT during Q3 2026 an increase of 68% compared to last quarter. • Urea prices decreased with improved availability with the advent of further Chinese export quotas. Intermittent Middle East vessel flow from within Hormuz complimented shipments from outside ports. Demand lulls lead to volatile pricing. 3. Specialites: The Specialties segment (which previously was part of the Polymers subsegment) comprises specialty resins, customized compounds, and reactive additives. Specialties Financial Overview: Item Three Months Ended Nine Months Ended Sep 30, 2026 Jun 30,2026 Sep 30, 2025 Sep 30, 2026 Sep 30, 2025 Gross Revenue 2.00 1.94 1.79 5.62 5.15 EBITDA3 0.41 0.38 0.30 1.23 0.80 Adjusted2 EBITDA3 0.47 0.38 0.30 1.29 0.90 Income from operations (EBIT1) 0.28 0.22 0.13 0.75 0.36 Adjusted2 EBIT1 0.33 0.22 0.14 0.81 0.50 All amounts in SAR billion unless otherwise stated. The USD/SAR conversion rate used is 3.75. Absolute amounts and percentages shown in this document have been subject to rounding adjustments. Please refer to the third quarter of 2026 Financial Statements. 1Earnings before interest and tax 2Reflects SABIC's underlying operational performance based on normal course of business by eliminating the effects of non-operational anomalies and one-offs. 3Income from operations (EBIT) plus depreciation, amortization, and impairment o Total Specialties sales volume of 65 KMT during Q3 2026 in line with Q2 volumes. • Demand AI Infrastructure growth continues to accelerate, higher average selling prices in Q3 driven by a favorable product mix.
Page 7
SABIC Earnings Release 7 4. Reconcilliation segments with overall group: Item Three Months Ended Sep 30, 2026 Petrochemicals Agri-Nutrients Specialties Corp Elimination Total Revenue 22.95 3.22 2.00 - - 28.17 EBITDA3 4.01 0.65 0.41 (0.36) 0.03 4.74 Adjusted2 EBITDA3 3.90 0.60 0.47 (0.25) 0.03 4.75 Income from operations (EBIT1) 1.70 0.45 0.28 (0.40) 0.03 2.06 Adjusted2 EBIT1 1.69 0.40 0.33 (0.29) 0.03 2.17 All amounts in SAR billion unless otherwise stated. The USD/SAR conversion rate used is 3.75. Absolute amounts and percentage s shown in this document have been subject to rounding adjustments. Please refer to the third quarter of 2026 Financial Statements. 1Earnings before interest and tax 2Reflects SABIC's underlying operational performance based on normal course of business by eliminating the effects of non -operational anomalies and one-offs. 3income from operations (EBIT) plus depreciation, amortization, and impairment Item Three Months Ended Jun 30, 2026 Petrochemicals Agri-Nutrients Specialties Corp Elimination Total Revenue 20.47 2.40 1.94 - - 24.81 EBITDA3 2.77 0.68 0.38 (0.13) 0.09 3.79 Adjusted2 EBITDA3 2.37 0.68 0.38 (0.13) 0.09 3.38 Income from operations (EBIT1) 0.08 0.49 0.22 (0.17) 0.09 0.71 Adjusted2 EBIT1 (0.19) 0.49 0.22 (0.21) 0.09 0.41 All amounts in SAR billion unless otherwise stated. The USD/SAR conversion rate used is 3.75. Absolute amounts and percentage s shown in this document have been subject to rounding adjustments. Please refer to the third quarter of 2026 Financial Statements. 1Earnings before interest and tax 2Reflects SABIC's underlying operational performance based on normal course of business by eliminating the effects of non -operational anomalies and one-offs. 3income from operations (EBIT) plus depreciation, amortization, and impairment Item Three Months Ended Sep 30, 2025 Petrochemicals Agri-Nutrients Specialties Corp Elimination Total Revenue 23.89 3.40 1.79 - - 29.08 EBITDA3 3.50 1.42 0.30 (0.18) - 5.04 Adjusted2 EBITDA3 3.55 1.42 0.30 (0.18) - 5.09 Income from operations (EBIT1) 1.14 1.22 0.13 (0.22) - 2.28 Adjusted2 EBIT1 1.19 1.22 0.14 (0.22) - 2.34 All amounts in SAR billion unless otherwise stated. The USD/SAR conversion rate used is 3.75. Absolute amounts and percentage s shown in this document have been subject to rounding adjustments. Please refer to the third quarter of 2026 Financial Statements. 1Earnings before interest and tax 2Reflects SABIC's underlying operational performance based on normal course of business by eliminating the effects of non -operational anomalies and one-offs. 3income from operations (EBIT) plus depreciation, amortization, and impairment
Page 8
SABIC Earnings Release 8 Item Nine Months Ended Sep 30, 2026 Petrochemicals Agri-Nutrients Specialties Corp Elimination Total Revenue 65.18 8.33 5.62 - - 79.13 EBITDA3 9.14 2.70 1.23 (0.62) 0.22 12.67 Adjusted2 EBITDA3 8.63 2.65 1.29 (0.51) 0.22 12.28 Income from operations (EBIT1) 1.87 2.12 0.75 (0.74) 0.22 4.22 Adjusted2 EBIT1 1.60 2.07 0.81 (0.67) 0.22 4.02 All amounts in SAR billion unless otherwise stated. The USD/SAR conversion rate used is 3.75. Absolute amounts and percentage s shown in this document have been subject to rounding adjustments. Please refer to the third quarter of 2026 Financial Statements. 1Earnings before interest and tax 2Reflects SABIC's underlying operational performance based on normal course of business by eliminating the effects of non -operational anomalies and one-offs. 3income from operations (EBIT) plus depreciation, amortization, and impairment Item Nine Months Ended Sep 30, 2025 Petrochemicals Agri-Nutrients Specialties Corp Elimination Total Revenue 73.78 9.64 5.15 - - 88.57 EBITDA3 9.34 3.74 0.80 (0.42) (0.07) 13.38 Adjusted2 EBITDA3 10.35 3.82 0.90 (0.42) (0.07) 14.57 Income from operations (EBIT1) 2.39 3.10 0.36 (0.53) (0.07) 5.25 Adjusted2 EBIT1 3.40 3.18 0.50 (0.53) (0.07) 6.47 All amounts in SAR billion unless otherwise stated. The USD/SAR conversion rate used is 3.75. Absolute amounts and percentage s shown in this document have been subject to rounding adjustments. Please refer to the third quarter of 2026 Financial Statements. 1Earnings before interest and tax 2Reflects SABIC's underlying operational performance based on normal course of business by eliminating the effects of non -operational anomalies and one-offs. 3income from operations (EBIT) plus depreciation, amortization, and impairment
Page 9
SABIC Earnings Release 9 OUTLOOK: Looking ahead, SABIC aims to continue focusing on sustainable long-term value creation through operational excellence, portfolio optimization, corporate transformation, and selective growth. The company maintains its disciplined approach to capital investment 1 with full-year expenditure guidance in the range of US$ 3 to 3.3 billion. 1 Capital expenditure (“CAPEX”) and capital injection for SABIC’s growth project, including CAPEX expensed off in the discontin ued businesses. Earnings Call: On October 26th at 3:30 p.m. GMT+3, SABIC will host a live Earnings call with its CEO and CFO to discuss the quarterly results, key priorities, and other matters. The recording, transcript, and presentation slides of the call will be posted on the company’s investor relations webpage. About SABIC: SABIC (TASI: 2010) ranks among the world’s largest petrochemicals manufacturers. It is a public company based in Riyadh, the Kingdom of Saudi Arabia. 70% of the company’s shares are owned by Aramco Downstream Company a wholly owned subsidiary of Saudi Aramco, with the remaining 30% publicly traded on the Saudi Exchange. SABIC serves customers in more than 140 countries with a global workforce of more than 26,000 talented individuals. To learn more about SABIC please visit www.sabic.com For further information, please contact SABIC Investor Relations at IR@SABIC.com or visit www.sabic.com/en/investors
Page 10
SABIC Earnings Release 10 Disclaimer: By reading this earning release, you recognize and agree to be bound by the following limitations. This earning release has been prepared for information and background purposes only. It does not constitute or form part of, and should not be construed as, an offer of, a solicitation of an offer to buy, or an invitation to subscribe for, underwrite or otherwise acquire, any securities of SABIC (the “Company”) or any other existing or future member of the SABIC Group (the “Group”) or any other company including Saudi Arabian Oil Co. (“Saudi Aramco”) or any other existing or future member of the Saudi Aramco Group, nor should it or any part of it form the basis of, or be relied on in connection with, any contract to purchase or subscribe for any securities of any such company or with any other contract or commitment whatsoever. This earning release does not constitute a prospectus in whole or in part, and any decision to invest in securities should be made solely on the basis of the information to be contained in a prospectus and on an independent analysis of the information contained therein. Any assumptions, views or opinions contained in this earning release represent the assumptions, views or opinions of the Company as of the date indicated and are subject to change without notice. All information not separately sourced is from Company data and estimates. Information contained in this earning release related to past performance is not an indication of future performance and is not intended to predict actual results, and no assurances are given with respect thereto. The information contained in this earning release has not been independently verified, and no representation or warranty, express or implied, is made as to the fairness, accuracy, completeness or correctness of the information contained herein, and no reliance should be placed on it. Neither the Company nor its affiliates, advisers, connected persons or any other person accepts any liability for any loss howsoever arising (in negligence or otherwise), directly or indirectly, from this earning release or its contents or otherwise arising in connection with this earning release. This shall not, however, restrict or exclude or limit any duty or liability to a person under any applicable law or regulation of any jurisdiction which may not lawfully be disclaimed. This earning release may include statements that are, or may be deemed to be, “‘forward-looking statements.” These statements often contain words such as “anticipate,” “believe,” “intend,” “estimate,” “expect” “outlook,” “will,” “will be,” “will Continue,” “would” and similar expressions, and variations or negatives of these words or phrases. All statements other than statements of historical facts included in this earning release are forward- looking statements. By their nature, such forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause the actual results, performance or achievements of the Company to be materially different from results, performance or achievements expressed or implied by such forward-looking statements. Such forward-looking statements are based on numerous assumptions regarding the Company’s present and future business strategies and the market environment in which the Company will operate in the future. These forward-looking statements speak only as of the date of this earning release. Each of the Company and its affiliates and their respective shareholders, agents, employees and advisers, expressly disclaims any obligation or undertaking to update any forward-looking statements contained herein. You are urged to consider these factors carefully in evaluating the forward-looking statements in this earning release and not to place undue reliance on such statements. This earning release is not directed to, or intended for distribution to or use by, any person or entity that is a citizen or resident or located in any locality, state, country or other jurisdiction where such distribution, publication, availability or use would be contrary to law or regulation of such jurisdiction or which would require any registration or licensing within such jurisdiction. Any failure to comply with these restrictions may constitute a violation of the laws of other jurisdictions. Average sales prices stated in this earning release includes FX and other factors. The information contained in this earning release is provided as of the date of this earning release and is subject to change without notice. © 2026 Copyright by SABIC. All rights reserved.